These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6526643)

  • 1. Proteoglycan modifications in cultured osteogenesis imperfecta skin fibroblasts.
    De Luca G; Tira ME; Rindi S; Salvini R; Cetta G; Castellani AA
    Ital J Biochem; 1984; 33(6):403-12. PubMed ID: 6526643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of proteoglycans produced by human skin fibroblast cultures during replicative senescence.
    Passi A; Albertini R; Bardoni A; Rindi S; Salvini R; Pallavicini G; De Luca G
    Cell Biochem Funct; 1993 Dec; 11(4):263-9. PubMed ID: 8275551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum.
    Passi A; Albertini R; Baccarani Contri M; de Luca G; de Paepe A; Pallavicini G; Pasquali Ronchetti I; Tiozzo R
    Cell Biochem Funct; 1996 Jun; 14(2):111-20. PubMed ID: 8640951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta.
    Dyne KM; Valli M; Forlino A; Mottes M; Kresse H; Cetta G
    Am J Med Genet; 1996 May; 63(1):161-6. PubMed ID: 8723103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphofunctional aspects of genetic analysis of osteogenesis imperfecta in cultured skin fibroblasts].
    Meerson EM; Barer FS; Berezhnyĭ AP; Prokhorova EV; Maliavko TP; Chernysheva EV; Neustroeva EP
    Biull Eksp Biol Med; 1992 Jul; 114(7):86-8. PubMed ID: 1421323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycan alterations in osteogenesis imperfecta.
    Cetta G; Lenzi L; Balduini C; Valli M; Tenni R; De Luca G; Castellani AA
    Ital J Biochem; 1980; 29(5):337-50. PubMed ID: 7203991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cells unable to express decoron produced disorganized extracellular matrix lacking "shape modules" (interfibrillar proteoglycan bridges).
    Scott JE; Dyne KM; Thomlinson AM; Ritchie M; Bateman J; Cetta G; Valli M
    Exp Cell Res; 1998 Aug; 243(1):59-66. PubMed ID: 9716449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal production of procollagen in fibroblast culture in a case of osteogenesis imperfecta].
    Supervía A; Díez A; Nácher M; Nogués X
    Med Clin (Barc); 1998 Nov; 111(18):719. PubMed ID: 9887442
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action.
    Galicka A; Nazaruk J
    Int J Mol Med; 2007 Dec; 20(6):889-95. PubMed ID: 17982699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro sulfate turnover in osteogenesis imperfecta congenita and tarda.
    Delvin EE; Glorieux FH; Lopez E
    Am J Med Genet; 1979; 4(4):349-55. PubMed ID: 539603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI.
    Forlino A; Kuznetsova NV; Marini JC; Leikin S
    Matrix Biol; 2007 Oct; 26(8):604-14. PubMed ID: 17662583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of hyaluronic acid and collagen in skin fibroblasts cultured from patients with osteogenesis imperfecta.
    Turakainen H; Larjava H; Saarni H; Penttinen R
    Biochim Biophys Acta; 1980 Apr; 628(4):388-97. PubMed ID: 6768402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in human bone proteoglycan structure. Impact of osteogenesis imperfecta.
    Grzesik WJ; Frazier CR; Shapiro JR; Sponseller PD; Robey PG; Fedarko NS
    J Biol Chem; 2002 Nov; 277(46):43638-47. PubMed ID: 12221073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collagen analysis in fibroblasts in osteogenesis imperfecta. Clinical benefits].
    Finne PH; Heiberg A; Holmström H
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1469-73. PubMed ID: 9178973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of adhesion properties and proteoglycan structure in rat embryo fibroblast cultures with increasing passages.
    Pippia P; Formato M; Sciola L; Tilloca G; Bardoni A; Pallavicini G; Passi A; Rindi S; Salvini R; De Luca G
    Cell Biochem Funct; 1992 Sep; 10(3):217-24. PubMed ID: 1423902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered glycosaminoglycan production in cultured osteogenesis-imperfecta skin fibroblasts.
    Turakainen H
    Biochem J; 1983 Jul; 213(1):171-8. PubMed ID: 6615420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV.
    Galicka A; Wolczynski S; Gindzienski A
    J Pathol; 2002 Feb; 196(2):235-7. PubMed ID: 11793376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis.
    Westergren-Thorsson G; Cöster L; Akesson A; Wollheim FA
    J Rheumatol; 1996 Aug; 23(8):1398-406. PubMed ID: 8856620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.